D
IBB icon

Diversified’s iShares Biotechnology ETF IBB Stock Holding History

Diversified’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-1,762
Closed -$215K – 162
2023
Q3 		$215K Buy
+1,762
New +$224K 0.06% 131
2023
Q2 		– Sell
-2,511
Closed -$324K – 149
2023
Q1 		$324K Sell
2,511
-122
-5% -$16K 0.12% 97
2022
Q4 		$346K Sell
2,633
-103
-4% -$13.3K 0.14% 100
2022
Q3 		$320K Sell
2,736
-148,397
-98% -$18.4M 0.16% 78
2022
Q2 		$17.8M Buy
+151,133
New +$17.9M 7.38% 4
2021
Q1 		– Sell
-540
Closed -$73K – 192
2020
Q4 		$73K Buy
+540
New +$77.2K 0.06% 158

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
CB
Commerce Bank Kansas City, Missouri $20.7B AUM 23.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Diversified's IBB Position: Q4 2023 in Review

Diversified sold out of iShares Biotechnology ETF (IBB) in Q4 2023, closing a stake of 1,762 shares — an estimated $215K sold.

Diversified first reported a position in IBB in Q4 2020 and held it in 6 quarters. The position peaked at $17.8M in Q2 2022. 872 funds tracked by Wall St. Rank hold IBB as of Q4 2023.

  • Diversified reported no remaining iShares Biotechnology ETF position as of Q4 2023 after selling out during the quarter.
  • Diversified sold 1,762 iShares Biotechnology ETF shares in Q4 2023, an estimated $215K.
  • Diversified first reported a position in iShares Biotechnology ETF in Q4 2020 and held it in 6 quarters.
  • Diversified's iShares Biotechnology ETF position peaked at $17.8M in Q2 2022.
  • 872 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q4 2023.

Based on Diversified's 13F filing for Q4 2023, filed 1 Feb 2024.